Uterine fibroids are the commonest tumor affecting the female reproductive tract and many instances they are asymptomatic but in some women there does appear to be an association with heavy menstrual blood loss and possibly subfertility. Classically, treatment has been surgical with hysterectomy the most common approach for women who have completed their fertility and myomectomy for those who wish to conceive. The surgery can be carried out laparoscopically, vaginally and abdominally. The aim of this study is to evaluate the risk of hysterectomy at the time of myomectomy, and the associated 30-day postoperative morbidity.
Study Type
OBSERVATIONAL
Enrollment
293
Faculty of Medicine, Ain Shams University
Cairo, Egypt
Incidence of hysterectomy at time of myomectomy.
Time frame: Jan 2020- Dec 2024
Characteristics of the Myomas who required hysterectomy
number, site, size, Figo staging
Time frame: Jan 2020- Dec 2024
Intraoperative complications
Anesthesia complication, organ injury, blood transfusion.
Time frame: Jan 2020- Dec 2024
Postoperative complications
Anemia, hemorrhage, fever, wound infection, wound hematoma
Time frame: Jan 2020- Dec 2024
Duration of hospital stay
in days
Time frame: Jan 2020- Dec 2024
Reoperation
within 5 days of surgery
Time frame: Jan 2020- Dec 2024
Readmission after discharge from the hospital
within 14 days
Time frame: Jan 2020- Dec 2024
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.